She also collaborates on several other projects examining the influence of
immune molecules on prenatal brain development and their role in the genesis of schizophrenia, major depression, and cardiovascular disease in adults.
Not exact matches
On its own, the
immune system boasts different
molecules that detect harmful intruders, eradicate small infections and work to contain larger outbreaks.
SOUTH SAN FRANCISCO, Calif. — February 5, 2018 — FLX Bio, Inc., a biopharmaceutical company focused
on the discovery and development of oral small
molecule drugs to activate the
immune system against cancer, today announced the appointment of senior pharmaceutical research and development executive Michael F. Giordano, M.D., to its Board of Directors.
The Company focuses
on discovering and developing small
molecule drugs directed against tumor and
immune cell targets that control key metabolic pathways in the tumor microenvironment.
They use
molecules on the bacteria's surfaces as reins, to ride towards host cells, or backstage passes to sneak past the
immune system.
The
immune system depends
on molecules called T cell receptors
on the surface of T cells to recognize and respond to foreign antigens from virus - infected cells, tumors and other threats.
The Cologne molecular biologist is an expert
on root - colonizing fungi and the plant
immune system, the Würzburg chemist is a specialist for sugar
molecules and their functions in cells and organisms.
The experiments included sorting
immune cells found at injury sites by
molecules on their cellular surfaces, and many hours looking at mouse cells through the microscope.
This drug (vedolizumab) blocks a specific adhesion
molecule on the surface of the T - cell and thereby inhibits
immune cells from binding themselves to receptors present in the intestine, preventing the T - cells from penetrating the blood vessels in the intestinal tissue.
In this study, the SIgN team discovered for the first time that the integrity of p53 affects the production of a special cell surface protein called Major Histocompatibility Complex (MHC) class I. MHC class I
molecules on the cancer cell surface serve as targets for the
immune system.
But when the
immune system becomes activated in response to an illness or injury, glia in regions associated with pain processing seem to take
on another role: They release inflammatory
molecules that interact with nearby neurons to amplify pain signals.
The test relies
on clues found in the rise and fall of the abundance of
molecules that play a role in the body's
immune response.
The idea is that routine exposure to harmless microorganisms in the environment — soil bacteria, for instance — trains our
immune systems to ignore benign
molecules like pollen or the dandruff
on a neighbor's dog.
One key gene encodes the making of a receptor called TREM2, a docking site for
molecules on the surface of microglia and other innate
immune cells.
To bring the wrath of the
immune system down
on tumors, researchers have tried shooting them up with a variety of
molecules and viruses.
Patterson, one of the few scientists who began studying the role of
immune molecules in neurons before Shatz, has long focused
on cytokines, messenger
molecules that regulate inflammation in the body and (as Patterson eventually discovered) act as growth factors in the developing brain.
Interferons are
molecules produced by cells in response to viral or bacterial infection, and which act
on neighboring cells to prevent the spread of the infection, shut down protein synthesis, and activate the
immune system.
To find out, the team genetically modified mice to block production of Nppb in TRPV1 neurons, then injected the skin
on their shoulders with a range of itch - inducing compounds, including histamine, an inflammatory
molecule involved in
immune responses, and the malaria drug chloroquine.
The vaccines rely
on training the
immune system to make defensive antibody
molecules.
The
immune system may kick in when animals eat, releasing reactive oxygen
molecules to kill microbes
on food, helping to protect from disease.
As with innate immunity, the adaptive
immune system — the T cells and antibodies produced by B cells that target specific
molecules on invading cells — contributes to pathology or may also fight against it.
The two drug combination «reveals the possibilities of combining an
immune signaling
molecule with taking the brakes off at the same time,» said F. Stephen Hodi, MD, first author
on the clinical trial report.
They looked specifically for genes coding the major histocompatibility complex (MHC)-- a
molecule found
on the surface of cells that acts as a crucial component of the
immune systems of most vertebrates.
The genes revealed the array of
immune system signaling
molecules and steroid hormones taking part in the
immune attack
on the embryo.
Allison pioneered
immune checkpoint blockade, an approach that treats the
immune system, rather than the tumor directly, by blocking
molecules on T cells that shut those attack cells down, protecting tumors from
immune response.
They are extremely potent
molecules, however, so even small changes in interferon - levels can have dramatic effects
on the
immune system.
PD - 1 (programmed cell death protein 1) is a receptor
on the surface of T cells (the white blood cells that are part of the
immune system), while PD - L1 (programmed death - ligand 1) is a
molecule that binds to PD - 1 and is often over-expressed
on the surface of cancer cells, enabling them to evade the
immune system and allow cancer to grow and spread.
The importance of this interaction between ILC3s and T cells for the
immune defense was shown in mice that were lacking the MHC
molecules on their ILC3s.
A new class of drugs called
immune checkpoint inhibitors block
molecules on T cells that shut down
immune response, freeing the
immune system to attack tumors.
Their preliminary results identified two types of
immune cells, CD4 + and CD8 + T cells, which become mobilized to attack various surface
molecules on the TB bacterium.
This
molecule, a type of sugar, has become chemically glued to a location
on the virus's surface near where human antibodies —
immune system watchdogs — attach to mark the virus as a dangerous invader.
Molecules produced
on demand by the host's genes have lots of different jobs that might help or hurt the bugs:
immune responses, digestive enzymes, physiological «climate control» and metabolism, among others.
Tumor cells often over express these checkpoint
molecules, putting the brakes
on the
immune system's search and destroy work.
They have detected, for example, revved up signaling
molecules involved in inflammation, such as tumor necrosis factor α (TNFα) and other cytokines; skewed populations of natural killer cells and other
immune cells; imbalances in the protein - destroying enzymes called proteases; and a shortening of the telomeres, the «end caps»
on chromosomes, which indicates prematurely aged cells.
IL - 6 is a cytokine, a signal
molecule that is produced and secreted both by
immune cells and by tumor cells and binds specifically to a receptor (IL - 6R) that is found
on the surfaces of many cell types.
The researchers modified a type of human
immune cell — called T lymphocytes, or T cells — to target a
molecule called CS1, which is found
on more than 95 percent of myeloma cells, and to kill the cells.
By engineering red blood cells to have «sticky» proteins
on their surface, a team of researchers has given the cells the ability to carry anything from drugs to treat
immune disorders or cancer to radioactive
molecules used in imaging of blood vessels.
«Zika virus may cause microcephaly by hijacking human
immune molecule: Fetal brain model provides first clues
on how Zika virus blunts brain development; blocking mechanism reduces cell damage.»
AMD3100, alone or in combination with VIC - 008, decreases expression of the
immune checkpoint
molecule PD - 1
on CD8 T cells, implying that the CXCR4 / CXCR12 pathway modulates PD - 1 expression.
Certain
molecules on tumors can serve as targets for attack by cells of the
immune system.
The researchers went
on to identify the
immune networks underlying IL - 33's harmful effects and discovered that this
molecule activates
immune cells called type 2 innate lymphoid cells (ILC2), which had never before been linked to liver disease.
Therapies based
on immune cells, which target particular tumor
molecules, are more specific, but they are not effective against a variety of tumors.
Neoantigens are
molecules on cell's surfaces that are produced by DNA mutations that are present in cancer cells but not in normal cells, making neoantigens ideal targets for
immune therapy against cancer, say the scientists.
When the team monitored the vaccine's effects
on the
immune system in each patient, they found that both T cell types had indeed been activated by the vaccine and could recognize the neoantigens bound to HLA
molecules.
Checkpoint blockade: Fewer but stronger results Allison pioneered
immune checkpoint blockade, an approach that treats the
immune system, rather than the tumor directly, by blocking
molecules on T cells that shut those attack cells down, protecting tumors from
immune response.
«It was known that acute exposure to pyrethroids could lead to
immune dysfunction, and that the
molecules they act
on can be found in
immune cells; now we need to know more about how longer - term exposure affects the
immune system in a way that increases risk for Parkinson's.»
2B4 is an inhibitory
molecule found
on immune cells.
Our findings show how the tumor microenvironment drives the acquisition of CD39 as an
immune regulatory
molecule on CD8 + T cells, with implications for defining a biomarker of T cell dysfunction and a target for immunotherapeutic intervention.
Affigen's focus is
on driving powerful
immune responses against
molecules unique to cancer, while minimizing the risk of damage to healthy tissues.
He's focused
on the physiopathology of severe malaria in pregnant women and children, with a special interest in the identification of clinically relevant cytoadhesion phenotypes in P. falciparum and P. vivax, in the host and parasite
molecules involved as well as in the targets of protective
immune mechanisms.